Identification of Bacterial and Fungal Isolates in Patients with Sinonasal Polyps
NCT06637449 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-10-15
Summary
To detect bacterial and fungal growth in patients with sinonasal polyps undergoing FESS
Conditions
- Sinonasal Polyps
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-15
- Primary Completion
- 2026-10-01
- Completion
- 2026-12-01
More Related Trials
-
Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
NCT00620074 ·Status: TERMINATED ·Phase: PHASE4
-
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT06105411 ·Status: RECRUITING
-
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
NCT01823289 ·Status: COMPLETED ·Phase: PHASE4
-
Immunity and Nasal Fungal Colonization
NCT05231499 ·Status: COMPLETED
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
NCT06344117 ·Status: RECRUITING
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095
NCT00177749 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)
NCT00704951 ·Status: WITHDRAWN
-
Clinical Trial of Pulmonary Cryptococcosis in China
NCT02503449 ·Status: UNKNOWN
-
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
NCT03672292 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
NCT03059992 ·Status: COMPLETED ·Phase: PHASE3
-
ATCF (Azole Therapy in Cystic Fibrosis)
NCT01576315 ·Status: COMPLETED ·Phase: PHASE2
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
NCT06028451 ·Status: RECRUITING
-
Study of FK463 for the Treatment of Invasive Aspergillosis
NCT00036166 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-mold Azole in the Prophylaxis for Invasive Fusariosis
NCT02714504 ·Status: COMPLETED ·Phase: NA
-
Comprehensive Diagnosis and Treatment Strategy for Opportunistic Fungal Infections in AIDS Patients
NCT05153005 ·Status: UNKNOWN
-
Factors Associated With Survival in Patients Having Pneumocystis Jirovecii
NCT06173453 ·Status: UNKNOWN
-
Markers of Infection and Resistance in Invasive Fusariosis
NCT04937751 ·Status: RECRUITING
-
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
NCT00531479 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
NCT06922344 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004808 ·Status: COMPLETED ·Phase: PHASE2